About LifeArc
LifeArc is a Financial Services company based in London (United Kingdom) founded in 1992. Medical research and treatments are supported by the community foundation. It operates on a Professional Services and Donation / Grant-Based model. Its chief executive, as recorded, is Melanie Lee. Its website lifearc.org draws about 20 thousand monthly visits. LifeArc offers products and services including Antibody Development, Small Molecule Drug Discovery, and Diagnostics Development. Its focus areas include Healthcare, Biotechnology, Drug Discovery and Medical Research. Its legal entity is LifeArc (Company No. 2698321).
Company details
LifeArc is engaged in translating promising scientific research into practical healthcare solutions. Activities are centered on drug discovery, antibody humanisation, diagnostics, and biomarker development. Sectors addressed include rare diseases, motor neuron disease, chronic respiratory conditions, childhood cancer, and global health challenges. Partnerships are formed to progress science towards commercial viability, while funding and investment are provided for early-stage ventures and open calls. Translational challenges are tackled by combining scientific expertise, advice, and collaborative efforts to deliver impactful patient outcomes.
- Headquarters London, United Kingdom
- SectorsFinancial Services
- Email••••••••
- Phone•••• ••••
- Website lifearc.org
- Social LinkedIn X
- Legal Name Lifearc (Company No. 2698321)
- Latest Funding Round$388.75K (USD), Grant
Apr 2016
Products & Services of LifeArc
LifeArc offers a comprehensive portfolio of products and services, including Antibody Development, Small Molecule Drug Discovery, and Diagnostics Development.
Antibody humanisation services are provided for therapeutic development.
Small molecule drugs are developed for various diseases.
Diagnostic tools are created for disease detection purposes.
Funding Insights of LifeArc
- Total Rounds 1
- Last Round Grant — $388,752
- First Round $388,752
(Apr 2016)
All 1 funding rounds of LifeArc with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2016 | $388,752 | Grant | – | – | – |
People of LifeArc
122 people are tracked at LifeArc (46 in leadership, 9 in board & advisors, 67 in team).
| Name | Role | Group |
|---|---|---|
Melanie Lee | Chief Executive Officer | Leadership |
Graham Duce | Chief Investment Officer | Leadership |
Claudia Montiel Equihua | Scientific Director | Leadership |
Derek Sheader | Head Of Partnerships, Motor Neurone Disease | Leadership |
Julie Brady | Interim Director, Business Development | Leadership |
Jeff Jerman | Head of Translational Matrix | Leadership |
John Park | Senior Director, Finance | Leadership |
Stéphane Maikovsky | Chief Financial Officer | Leadership |
Dave Powell | Chief Scientific Officer | Leadership |
Clare Terlouw | Head of LifeArc Ventures | Leadership |
Ghada Zoubiane | Head Of Global Health | Leadership |
Laura McCallum | Head Of Strategic Communications | Leadership |
Antony Smith | Head of Assay Development & Diagnostic Operations | Leadership |
George Orphanides | Chief Scientific Officer | Leadership |
Lone Friis | Scientific Director, Translational Matrix Group & Childhood Cancer | Leadership |
Pete Gardner | Scientific Director, Global Health | Leadership |
Fiona Roberts | Chief People Officer | Leadership |
Ed McIver | Scientific Director | Leadership |
Layla Evans | Head Of Events | Leadership |
Julie Robinson | Head Of Procurement | Leadership |
102 more people are available in the full profile.
Complete people profiles for LifeArc
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of LifeArc
2 dated milestones of LifeArc across 24 years, from founding to its latest funding, stage changes and deals.
- Founded LifeArc is founded.
- Funding First funding round of $389K.
Web traffic of LifeArc
The website of LifeArc (lifearc.org) receives about 20.1K visits a month.
- Monthly visits20.1K
▲ 17.5% vs previous month
Websites whose visitors overlap most with LifeArc. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
biochemistry.org | biochemistry.org | 100% | #688,331 | – | |
| hfsp.org | 98% | 60.1K | View details | ||
centreofthecell.org | centreofthecell.org | 92% | #1,532,098 | – | |
scilifelab.se | scilifelab.se | 85% | #239,989 | – | |
ukdri.ac.uk | ukdri.ac.uk | 81% | #645,910 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 7 similar websites and full traffic analytics for LifeArc
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Lifearc
Complete news archive for LifeArc
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about LifeArc
LifeArc was founded in 1992 and raised its 1st funding round 24 years after it was founded.
LifeArc is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Melanie Lee is the CEO of LifeArc, as recorded in our data.
LifeArc is engaged in translating promising scientific research into practical healthcare solutions. Activities are centered on drug discovery, antibody humanisation, diagnostics, and biomarker development. Sectors addressed include rare diseases, motor neuron disease, chronic respiratory conditions, childhood cancer, and global health challenges. Partnerships are formed to progress science towards commercial viability, while funding and investment are provided for early-stage ventures and open calls. Translational challenges are tackled by combining scientific expertise, advice, and collaborative efforts to deliver impactful patient outcomes.
LifeArc offers Antibody Development, Small Molecule Drug Discovery, and Diagnostics Development.
LifeArc operates through Lifearc (Company No. 2698321).